Introduction

86
Interest in minimally invasive mitral valve (MV) surgery through a video-assisted mini-87 thoracotomy approach (MIMVS) is rapidly growing since when was first introduced in the mid- has also been demonstrated to be a profound risk factor for mortality [5] . The weight of this 95 evidence has provided the impetus for the combination of surgical AF treatment and core cardiac 96 surgical intervention, with the hope of synergistic improvements in both sinus rhythm (SR) 97 maintenance and risk of morbidity and mortality [6, 7] .
98
Concomitant surgical AF ablation and mitral valve surgery have proved to offer improved short-99 and mid-term SR maintenance compared to patients undergoing mitral valve surgery only. No 100 differences were found between these two groups in terms of 30-day mortality, all-cause mortality, stratified by AF type, is reported in Figure 5 . Following transcatheter ablation, patients resulted in sinus rhythm for the remaining follow-up.
210
Based on the present experience, therefore, in the remote case of symptomatic arrhythmia relapses,
211
AF transcatheter ablation completing the surgical lesion set seems to easily avoid further 212 recurrences.
213
The cut-and-sew Cox-Maze III procedure has been the gold standard for surgical AF treatment and 
226
The principal shortcomings of the use of minimal access techniques is that, due to potential surgical and percutaneous ablation are emerging [24] .
Cryoablation during concomitant cardiac surgical procedures in sternotomy has appeared to be safe 
